BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms ...
Biovectra and Revolution Biomanufacturing have announced a collaboration that grants Biovectra access to Revolution Biomanufacturing's proprietary platforms to enhance mRNA stability and translational ...
Translation factors eIF1A and eIF5B are key repressors of an abnormal protein translation process linked to neurodegenerative ...
Living organisms synthesize a staggering variety of proteins by combining 20 amino acids into chains of any length and order. In the past, to expand protein diversity beyond the scope of these 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback